Peijun He

3.1k citations
25 papers · 2.3k indexed · h-index 19
Topics
MicroRNA in disease regulation (4 papers)Macrophage Migration Inhibitory Factor (4 papers)Epigenetics and DNA Methylation (3 papers)

In The Last Decade

Peijun He

24 papers receiving 2.2k citations

Peers

Peijun He
Comparison fields: 5 of 115
  • Molecular Biology 1.1k
  • Oncology 784
  • Cancer Research 670
  • Immunology 440
  • Pulmonary and Respiratory Medicine 258
Replace Xiangjian Luo with:
Xiangjian Luo China
Jim O’Prey United Kingdom
Qiong Shi China
Fumin Chang United States
Ming-Derg Lai Taiwan
Quansheng Zhou China
Wen Peng China
George G. Chen Hong Kong
Harris G. Yfantis United States
Stan Lightfoot United States
Peijun He relative to Xiangjian Luo China Xiangjian Luo's profile →
Citations per field
00.5×1.5×1.8×
Xiangjian Luo · 1×
Citations per year

Countries citing papers authored by Peijun He

Since Specialization
Citations

This map shows the geographic impact of Peijun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peijun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peijun He more than expected).

Fields of papers citing papers by Peijun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peijun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peijun He. The network helps show where Peijun He may publish in the future.

Co-authorship network of co-authors of Peijun He

This figure shows the co-authorship network connecting the top 25 collaborators of Peijun He. A scholar is included among the top collaborators of Peijun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peijun He. Peijun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 5
3 40
4 225
5 0
6 1
7 37
8 245
9 104
10 191
11 43
12 85
13 26
14 88
15 108
16 323
17
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
236
18 278
19 19
20 47

About Peijun He

Peijun He is a scholar working on Cancer Research, Biological Psychiatry and Immunology, having authored 25 papers that have together received 2.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Macrophage Migration Inhibitory Factor (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (670 citations), Oncology (784 citations) and Immunology (440 citations). Peijun He has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include S. Perwez Hussain, Curtis C. Harris, Makoto Nagashima, Thomas Ried, Jochen Gaedcke, Nader Hanna, H. Richard Alexander, Shu Okamura, Lorne J. Hofseth and Harris G. Yfantis. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026